Atezolizumab versus chemotherapy in patients with platinum-treated locally advanced or metastatic urothelial carcinoma (IMvigor211): a multicentre, open-label, phase 3 randomised controlled trial

Thomas B. Powles, Ignacio Durán, Michiel S. van der Heijden et al. · The Lancet · 2017

Cited by 1,408 works. doi:10.1016/s0140-6736(17)33297-x Open-access PDF

Authors

References